Skip to content

Pharmaceutical Care of Ambulatory Elderly Diabetes Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01455727
Enrollment
100
Registered
2011-10-20
Start date
2011-08-31
Completion date
Unknown
Last updated
2012-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Pharmaceutical care, Diabetes Mellitus

Brief summary

This trial will try to perform pharmaceutical care on ambulatory elderly diabetes patients. To provide appropriate diabetes education administration, identify and resolve drug-related problems, assess the appropriateness of their medications, establish the mechanism of medication consultations. Each patient will be assessed by the MMSE(Mini-Mental State Examination) and GDS(Geriatric Depression Scale). The effectiveness of pharmacist's intervention will be assessed by lab data and some questionnaires.

Interventions

OTHERPharmaceutical care

The Pharmacist provided Pharmaceutical care on the ambulatory elderly Diabetes patients, provided recommendation to the physician and reffered the patients to other diabetes-care-team members, including the CDEs and dietitians.

OTHERUsual care

Control patients received usual care directed by their physician.

Sponsors

Nantou Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age 65 years or older * A1c greater than or equal to 9.0

Exclusion criteria

* Not expected to live for the duration of the study * Unwillingness to participate and attend pharmacist visits * Unwillingness to participate the questionnaires(MMSE, GDS)

Design outcomes

Primary

MeasureTime frameDescription
Hgb A1c change12 monthbaseline, second measurement during 3 to 6 month after baseline, and the last measurement during 9 to 12 month after baseline

Secondary

MeasureTime frameDescription
Mini-Mental State Examination(MMSE) Score change1 yearbaseline and the second test was performed after 3 month.
Taiwan Geriatric Depression Scale(GDS) Score change1 yearbaseline and the second test was performed after 3 month.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026